We observed reduced expression of BTG2 upon p53 silencing, and restoration of BTG2 expression in p53-deficient cells reduced proliferation in vitro and reduced breast tumor growth at both primary and secondary sites in vivo. This evidence concerns the gene BTG2 and breast neoplasm.